This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Ironwood Pharmaceuticals Inc (IRWD)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 75.49M 136.70M 87.28M 44.32M
Receivables 3.21M 1.49M 652.00K 2.90M
Inventories 22.14M 6.70M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 229.13M 184.44M 167.57M 259.08M
Property, Plant & Equipment, Gross 79.06M 74.52M 59.38M 51.30M
Accumulated Depreciation & Depletion 41.69M 36.98M 25.76M 16.93M
Property, Plant & Equipment, Net 37.38M 37.54M 33.62M 34.37M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 12.46M 7.93M 7.78M 7.92M
Total Non-Current Assets 49.83M 45.47M 41.41M 42.29M
Liabilities & Shareholder Equity
Total Assets 278.96M 229.91M 208.98M 301.36M
Accounts Payable 10.19M 21.73M 6.44M 4.30M
Short Term Debt 1.14M 261.00K 233.00K 197.00K
Other Current Liabilities 2.79M 0.00 4.04M 2.80M
Total Current Liabilities 41.04M 54.94M 65.13M 64.43M
Long Term Debt 174.67M 0.00 0.00 0.00
Deferred Income Taxes 8.82M 11.59M 12.44M 14.61M
Other Non-Current Liabilities 13.07M 19.02M 21.13M 62.38M
Minority Interest 0.00 0.00 0.00 1.12M
Total Non-Current Liabilities 199.70M 30.92M 33.99M 77.39M
Total Liabilities 240.74M 85.86M 99.12M 141.81M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 38.22M 144.05M 109.86M 159.55M
Common Par 121.00K 108.00K 101.00K 99.00K
Additional Paid In Capital 815.93M 648.96M 542.14M 526.99M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -777.83M -505.02M -432.39M -367.54M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 2.00K 5.00K 6.00K 1.00K
Total Capitalization 212.90M 144.05M 109.86M 159.55M
Total Equity 38.22M 144.05M 109.86M 159.55M
Total Liabilities & Stock Equity 278.96M 229.91M 208.98M 301.36M
Total Common Shares Outstanding 121.17M 107.77M 100.72M 99.17M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 115.85M 106.40M 99.87M 89.65M
Diluted Weighted Shares Outstanding 115.85M 106.40M 99.87M 89.65M
Number of Employees 534 530 276 217
Number of Part-Time Employees 0 0 0 0

IRWD Ironwood Pharmaceuticals Inc

Analysts Ratings for IRWD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 4 3 3
Moderate Buy 0 0 0 0
Hold 3 3 3 4
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 1

Brokerage Partners

IRWD Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs